Introducing UnitVisID: An RFID Consortium Rebrand

Alliance revolves around interoperability of pharma products as they move through the supply chain


Originally known as DoseIDConsortium, a membership-driven industry alliance advancing radio-frequency identification (RFID) technology in pharmaceuticals, the group has now officially rebranded to UnitVisID Alliance. The name change reflects the organization’s commitment and mission to ensure the quality, performance, and interoperability of RFID-tagged pharma products as they move through the supply chain, from manufacturing to patient use.

With advancements in technology and innovation, RFID-tagged pharmaceutical products in the healthcare industry present opportunities to improve inventory management, and, better patient outcomes. Currently, UnitVisID is used by more than 1,000+ hospitals and healthcare organizations, and more than 210 million RFID-tagged products utilizing the UnitVisID platform have been scanned, which the consortium says is more than any other RFID system in the US healthcare space.

MPI is a proud UnitVisID Alliance member.

Get A
FREE Quote